Tesamorelin / Ipamorelin 15 mg (10/5)

TI-2026-003Lot 3A/TI15Analyzed November 6, 2026

Timeline

Ordered

October 27, 2026

Received

November 4, 2026

Analyzed

November 6, 2026

Sample

Name

Tesamorelin / Ipamorelin 15 mg (10/5)

Expected

Tesamorelin + Ipamorelin

Amount

1 vial, lyophilized powder

Testing

Client

3A Labz

Test type

Content & purity

Method

HPLC-UV

Content, how much is in it

Tesamorelin8.09mg

Label claim: 10 mg

Ipamorelin5.18mg

Label claim: 5 mg

Purity, how clean it is

99.9%

by HPLC-UV peak area, system peaks excluded

Chromatogram

HPLC-UV

8.68 min, Ipamorelin, 99.9%

13.65 min, Tesamorelin, 99.9%

Analyst Comments

White lyophilized powder, yellow-cap vial, received sealed.

Analyst Signature

Max Barrett

Lab Director, PuriLab Analytical

Analysis date: November 6, 2026

Verification Code

TI-PJ0U-R61T

Verify at purilab.org/verify/TI-PJ0U-R61T

Scan to Verify

TI-PJ0U-R61T

Results apply solely to the sample as received and are not representative of any larger lot, batch, or production run. Findings are limited to the analytes stated above. PuriLab Analytical is an independent testing laboratory, is not CLIA certified or ISO 17025 accredited, does not sell or distribute any substance, and makes no representation as to the safety, legality, or fitness of any material for any use.

PuriLab Analytical|admin@purilab.org

Page 1 of 1